(28 Feb 2023)
RESTRICTION SUMMARY:
ASSOCIATED PRESS
Shenzhen, China - 9 October 2018
1. Wide of scientist looking through microscope
2. Mid of two scientists
3. Close of computer monitor
ASSOCIATED PRESS
Shenzhen, China - 10 October 2018
4. Mid of He Jiankui
5. Mid of computer monitor
ASSOCIATED PRESS
Shenzhen, China - 9 October 2018
6. Close of microplate containing embryos
7. Mid of microplate containing embryos
8. Wide of scientist moving microplate onto microscope
9. Close of scientist looking through microscope
10. Close of an embryo receiving a small dose of Cas9 protein and PCSK9 sgRNA in a sperm injection microscope
11. Close of a monitor showing a video image of an embryo being held in place against a glass pipette via light negative pressure under a microscope
12. Close of hand moving controller
13. Mid of scientist and embryos on microscope
14. Close of back of scientist's head
15. Various of scientists through the glass
ASSOCIATED PRESS
Shenzhen, China - 10 October 2018
16. Wide of He Jiankui and colleague in the cubicle
17. Close of computer monitor
18. Mid of He Jiankui and colleague
ASSOCIATED PRESS
Shenzhen, China - 9 October 2018
19. Various of scientists looking at monitor
20. Various of monitor with embryo
ASSOCIATED PRESS
Beijing - 21 February 2023
21. Various STILLS of scientist He Jiankui speaking at a press conference
STORYLINE:
Five years ago, scientist He Jiankui shocked his peers and the world with claims that he created the first genetically edited babies. Now, after serving three years in a Chinese prison for practicing medicine without a license, he faces obstacles and critics as he tries to re-enter science.
For months he’s been touting plans to develop affordable gene therapies for rare diseases, starting with the muscle-wasting condition Duchenne muscular dystrophy. He announced on social media last fall that he had opened a lab in Beijing. He spoke remotely about this new endeavor at an event in early February hosted by the University of Kent in the United Kingdom.
And last week, he held a short press conference to announce he’d received a Hong Kong visa and might want to work in the financial hub. But Hong Kong officials revoked that visa hours later, saying false statements had been made and a criminal investigation would be launched.
The Associated Press has reached out to He several times by phone and email, but he has not agreed to an interview. Others in the scientific world, meanwhile, are divided about his efforts at a comeback — with some expressing serious doubts.
Some scientists worry he may return to the sort of work he did before, which involved using a tool called CRISPR-Cas9 to genetically edit embryos, disabling a gene that allows HIV to enter cells. The idea was to make children resistant to AIDS.
It's unclear how the three children who grew from the embryos — twins known as Lulu and Nana and a third child known as Amy — are doing.
A REVEALING TALK
Kent sociologist Joy Zhang, an organizer of the U.K. event where He spoke, said most participants were scientists and academics based in China, and many arrived with open minds about him and his latest project.
During his 25-minute presentation, He spent most of the time explaining basic science, discussing his Duchenne research for less than two minutes, according to a scathing report published by event organizers. That included sharing his goal to raise 50 million Chinese yuan through charity (about $7.3 million) and start clinical trials by March 2025.
He wouldn’t answer.
___
Find out more about AP Archive: [ Ссылка ]
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
You can license this story through AP Archive: [ Ссылка ]
